BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29073495)

  • 21. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
    Ben-Mustapha I; Agrebi N; Barbouche MR
    J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
    Shah S; Wu E; Rao VK; Tarrant TK
    Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
    Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
    J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
    Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
    Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaling the tips of the ALPS.
    Rieux-Laucat F; Kanellopoulos JM; Ojcius DM
    Biomed J; 2021 Aug; 44(4):383-387. PubMed ID: 34438083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monogenic defects in lymphocyte apoptosis.
    Fleisher TA; Oliveira JB
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):609-15. PubMed ID: 22918222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
    Teachey DT
    Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene defects in the soma: some get it and some don't!
    Lo B; Lenardo MJ
    J Clin Invest; 2011 Jan; 121(1):16-9. PubMed ID: 21183786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
    Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
    Rensing-Ehl A; Lorenz MR; Führer M; Willenbacher W; Willenbacher E; Sopper S; Abinun M; Maccari ME; König C; Haegele P; Fuchs S; Castro C; Kury P; Pelle O; Klemann C; Heeg M; Thalhammer J; Wegehaupt O; Fischer M; Goldacker S; Schulte B; Biskup S; Chatelain P; Schuster V; Warnatz K; Grimbacher B; Meinhardt A; Holzinger D; Oommen PT; Hinze T; Hebart H; Seeger K; Lehmberg K; Leahy TR; Claviez A; Vieth S; Schilling FH; Fuchs I; Groß M; Rieux-Laucat F; Magerus A; Speckmann C; Schwarz K; Ehl S;
    J Allergy Clin Immunol; 2024 Jan; 153(1):297-308.e12. PubMed ID: 37979702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
    Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
    Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
    Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
    Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
    Takagi M; Shinoda K; Piao J; Mitsuiki N; Takagi M; Matsuda K; Muramatsu H; Doisaki S; Nagasawa M; Morio T; Kasahara Y; Koike K; Kojima S; Takao A; Mizutani S
    Blood; 2011 Mar; 117(10):2887-90. PubMed ID: 21063026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
    Magerus-Chatinet A; Neven B; Stolzenberg MC; Daussy C; Arkwright PD; Lanzarotti N; Schaffner C; Cluet-Dennetiere S; Haerynck F; Michel G; Bole-Feysot C; Zarhrate M; Radford-Weiss I; Romana SP; Picard C; Fischer A; Rieux-Laucat F
    J Clin Invest; 2011 Jan; 121(1):106-12. PubMed ID: 21183795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
    Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
    Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.
    Aberdein D; Munday JS; Gandolfi B; Dittmer KE; Malik R; Garrick DJ; Lyons LA;
    Mamm Genome; 2017 Feb; 28(1-2):47-55. PubMed ID: 27770190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.